CD274 and neoplasm: ICIs disturb the immunosuppressive interaction between checkpoint proteins on T cells (e.g., PD-1) and their ligands on tumor cells (e.g., PD-L1) thereby unleashing T cell-mediated cytotoxicity towards the tumor [34].